...
首页> 外文期刊>Internal medicine journal >Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: A case-control study
【24h】

Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: A case-control study

机译:质子泵抑制剂与住院患者难治性梭状芽胞杆菌感染相关的腹泻:病例对照研究

获取原文
获取原文并翻译 | 示例

摘要

The incidence and disease severity of Clostridium difficile infection are rising. There is increasing evidence of a potential association between proton-pump inhibitors (PPI) and C.difficile infection. We performed a case-control study to examine the relationship between PPI and polymerase chain reaction (PCR)-proven C.difficile infection in 137 hospitalised patients in a tertiary hospital in Western Australia. Only antibiotic exposure within 3months prior to onset of diarrhoea was associated with PCR-proven C.difficile infection (odds ratio 5.97, 95% confidence interval 2.40-14.8, P= 0.001). A restricted analysis on those who had exposure to antibiotics within 3months before the onset of diarrhoea did not change the negative association between PPI exposure and PCR-proven C.difficile infection. Long-term PPI usage and intensity of PPI exposure prior to onset of diarrhoea were not significantly associated with C.difficile infection.
机译:艰难梭菌感染的发病率和疾病严重性正在上升。越来越多的证据表明质子泵抑制剂(PPI)和艰难梭菌感染之间可能存在关联。我们进行了一项病例对照研究,以检查西澳大利亚一家三级医院的137例住院患者中PPI与聚合酶链反应(PCR)验证的艰难梭菌感染之间的关系。仅在腹泻发作前3个月内接触抗生素才与PCR证实的艰难梭菌感染有关(优势比5.97,95%置信区间2.40-14.8,P = 0.001)。对腹泻发作前3个月内接触抗生素的人群进行的限制性分析并未改变PPI暴露与PCR验证的艰难梭菌感染之间的负相关性。腹泻开始前长期服用PPI和PPI暴露强度与艰难梭菌感染无显着相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号